Imricor Medical Systems Inc (ASX:IMR)
A$ 0.49 -0.03 (-5.77%) Market Cap: 123.67 Mil Enterprise Value: 137.83 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Full Year 2022 Imricor Medical Systems Inc Earnings Call Transcript

Feb 22, 2023 / 10:00PM GMT
Release Date Price: A$0.309899 (+1.59%)
Simon Hinsley
NWR Communications Pty Ltd - Director

Good morning, and welcome to Imricor's Financial Year 2022 Full Year Results. On the line today, we have Steve Wedan, company's CEO; and the company's CFO, Jonathon Gut.

Before I hand it over to Steve and Jon to go through the presentation up on the screen, I'll just remind you that we will conduct a Q&A session at the end of the presentation, and you can ask questions through the Q&A panel at the bottom of your screen.

Steve, I'll now hand it over to you. Thanks very much.

Steve Wedan
Imricor Medical Systems, Inc. - President, CEO & Executive Chairman

Thanks, and hello, everyone, and thank you for joining us today to discuss Imricor's full year results. Again, I am Steve Wedan, Imricor's Chair and CEO, and I'm joined by our CFO, Jonathon Gut. Today, we'll provide you with the business update on the progress we have made during 2022, including our key achievements and the progress we made on our overall strategy. Jon will then discuss the financial results before I summarize

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot